Putnam Investments’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $16.6M | Sell |
200,914
-41,554
| -17% | -$3.17M | 0.02% | 254 |
|
|
2023
Q3 | $19M | Buy |
242,468
+8,308
| +4% | +$695K | 0.03% | 215 |
|
|
2023
Q2 | $20.6M | Sell |
234,160
-39,571
| -14% | -$3.41M | 0.03% | 201 |
|
|
2023
Q1 | $22.1M | Sell |
273,731
-132,802
| -33% | -$10.8M | 0.04% | 198 |
|
|
2022
Q4 | $31.6M | Sell |
406,533
-51,268
| -11% | -$4.16M | 0.06% | 169 |
|
|
2022
Q3 | $37M | Buy |
457,801
+16,434
| +4% | +$1.48M | 0.07% | 155 |
|
|
2022
Q2 | $39.6M | Sell |
441,367
-222,048
| -33% | -$22.5M | 0.07% | 158 |
|
|
2022
Q1 | $73.6M | Sell |
663,415
-962,405
| -59% | -$102M | 0.11% | 139 |
|
|
2021
Q4 | $168M | Sell |
1,625,820
-40,282
| -2% | -$4.66M | 0.24% | 104 |
|
|
2021
Q3 | $209M | Sell |
1,666,102
-176,583
| -10% | -$22.9M | 0.32% | 92 |
|
|
2021
Q2 | $229M | Buy |
1,842,685
+246,864
| +15% | +$31M | 0.36% | 81 |
|
|
2021
Q1 | $189M | Buy |
1,595,821
+567,889
| +55% | +$66.6M | 0.31% | 91 |
|
|
2020
Q4 | $120M | Buy |
1,027,932
+299,871
| +41% | +$33M | 0.21% | 111 |
|
|
2020
Q3 | $75.7M | Buy |
728,061
+11,650
| +2% | +$1.17M | 0.15% | 131 |
|
|
2020
Q2 | $65.7M | Sell |
716,411
-271,644
| -27% | -$26M | 0.14% | 132 |
|
|
2020
Q1 | $89.1M | Sell |
988,055
-284,076
| -22% | -$30.2M | 0.23% | 110 |
|
|
2019
Q4 | $144M | Buy |
1,272,131
+280,479
| +28% | +$30.8M | 0.3% | 97 |
|
|
2019
Q3 | $108M | Buy |
991,652
+37,136
| +4% | +$3.87M | 0.24% | 117 |
|
|
2019
Q2 | $93M | Buy |
954,516
+159,339
| +20% | +$14.5M | 0.21% | 129 |
|
|
2019
Q1 | $72.4M | Buy |
795,177
+134,186
| +20% | +$12M | 0.17% | 138 |
|
|
2018
Q4 | $60.1M | Buy |
660,991
+645,843
| +4,264% | +$60.4M | 0.16% | 136 |
|
|
2018
Q3 | $1.49M | Buy |
15,148
+144
| +1% | +$13.3K | ﹤0.01% | 797 |
|
|
2018
Q2 | $1.28M | Sell |
15,004
-2,270
| -13% | -$190K | ﹤0.01% | 816 |
|
|
2018
Q1 | $1.39M | Sell |
17,274
-629
| -4% | -$51.9K | ﹤0.01% | 793 |
|
|
2017
Q4 | $1.45M | Sell |
17,903
-4,300
| -19% | -$344K | ﹤0.01% | 816 |
|
|
2017
Q3 | $1.73M | Sell |
22,203
-2,300
| -9% | -$191K | ﹤0.01% | 806 |
|
|
2017
Q2 | $2.17M | Sell |
24,503
-1,900
| -7% | -$160K | 0.01% | 770 |
|
|
2017
Q1 | $2.13M | Sell |
26,403
-1,240,592
| -98% | -$96.9M | 0.01% | 847 |
|
|
2016
Q4 | $90.2M | Sell |
1,266,995
-138,271
| -10% | -$10.9M | 0.22% | 121 |
|
|
2016
Q3 | $121M | Sell |
1,405,266
-439,925
| -24% | -$38.3M | 0.29% | 90 |
|
|
2016
Q2 | $160M | Buy |
1,845,191
+9,303
| +0.5% | +$752K | 0.39% | 62 |
|
|
2016
Q1 | $138M | Sell |
1,835,888
-213,102
| -10% | -$16.1M | 0.33% | 71 |
|
|
2015
Q4 | $158M | Sell |
2,048,990
-9,547
| -0.5% | -$719K | 0.36% | 61 |
|
|
2015
Q3 | $138M | Sell |
2,058,537
-850,605
| -29% | -$62.6M | 0.31% | 72 |
|
|
2015
Q2 | $216M | Sell |
2,909,142
-489,763
| -14% | -$37.4M | 0.43% | 48 |
|
|
2015
Q1 | $265M | Buy |
3,398,905
+679,242
| +25% | +$51.5M | 0.53% | 37 |
|
|
2014
Q4 | $196M | Buy |
2,719,663
+387,836
| +17% | +$26.9M | 0.4% | 51 |
|
|
2014
Q3 | $144M | Buy |
2,331,827
+1,749,929
| +301% | +$111M | 0.31% | 79 |
|
|
2014
Q2 | $37.1M | Sell |
581,898
-83,423
| -13% | -$5.07M | 0.08% | 234 |
|
|
2014
Q1 | $40.9M | Sell |
665,321
-1,699
| -0.3% | -$99K | 0.09% | 216 |
|
|
2013
Q4 | $38.3M | Buy |
667,020
+8,666
| +1% | +$491K | 0.09% | 224 |
|
|
2013
Q3 | $35.1M | Buy |
658,354
+5,036
| +0.8% | +$271K | 0.09% | 227 |
|
|
2013
Q2 | $33.6M | Buy |
+653,318
| New | +$32.3M | 0.1% | 223 |
|
Other funds holding MDT
Putnam Investments's MDT Position: Q4 2023 in Review
Putnam Investments reduced its Medtronic (MDT) stake by 17% in Q4 2023, selling an estimated $3.17M and leaving 200,914 shares worth $16.6M. The position accounts for 0.02% of the portfolio, ranked #254.
Putnam Investments first reported a position in MDT in Q2 2013 and has held it in 43 quarters since. The position peaked at $265M in Q1 2015. 2,074 funds tracked by Wall St. Rank hold MDT as of Q4 2023.
- Putnam Investments held 200,914 shares of Medtronic worth $16.6M as of Q4 2023.
- Putnam Investments sold 41,554 Medtronic shares in Q4 2023, an estimated $3.17M.
- Medtronic made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #254 holding.
- Putnam Investments first reported a position in Medtronic in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Medtronic position peaked at $265M in Q1 2015.
- 2,074 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.